Tyra Biosciences, San Jose, CA, Remote
Tyra Biosciences, Inc. is seeking a highly motivated VP, Asset Lead to make impactful contributions to oncology drug development projects targeting disease areas with high unmet medical need. The successful candidate will be highly organized, self-motivated, and thrive in a dynamic, cross-functional start-up environment.
This position requires broad knowledge and experience across the clinical development spectrum, specifically late-stage development. This individual is the matrix leader with overall, end-to-end accountability for a drug's development, from late-stage clinical trials through registration, launch, and life cycle management. At the P3 stage, theVP, Asset Lead will focus on generating integrated evidence for regulatory submission, optimizing commercial strategy, and ensuring cross-functional alignment to maximize the asset's value.
Reporting in the COO candidates must have experience optimizing commercial strategy and ensuring cross-functional alignment to maximize the asset's value. This includes Commercialization Prep(see below).
Base Salary Range : $346,500 - $362,700 USD
Individual compensation will be determined based on factors such as work location, skills, education, training, and experience.
What we offer US-based Employees:
Equal Opportunity Employer : Tyra Biosciences, Inc. is an equal opportunity employer that is committed to providing a work environment free of harassment and discrimination based upon a protected category, as well as an environment free from retaliation for protected activity.
Notice to Recruiters and Third-Party Agencies: The Talent Acquisition team manages the recruitment and employment process for Tyra. To protect the interests of all parties involved, Tyra will only accept resumes from a recruiter once a fully-executed search agreement is in place. Agencies are hereby specifically directed not to contact Tyra employees directly in an attempt to present candidates. Tyra will consider any candidate for whom an Agency and/or Recruiter has submitted an unsolicited resume to have been referred, free of any charges or fees.
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNÅP, enables the rapid and precise refinement of structural drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. TYRA is based in Carlsbad, CA.
View company profile →